Enveric Biosciences, Inc. (ENVB) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 3 买入, 1 持有.
分析师预估 每股收益(EPS)为 $-208.80 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-19.04 vs 预期 $-208.80 (超预期 +90.9%). 2025: 实际 $-36.24 vs 预期 $-154.80 (超预期 +76.6%). 分析师准确度: 0%.
ENVB 分析师评级
Buy
基于过去3个月内 4 位分析师对 Enveric Biosciences, Inc. 的评级
EPS 预测 — ENVB
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$19.04
vs Est –$208.80
▲ 996.6% off
2025
Actual –$36.24
vs Est –$154.80
▲ 327.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ENVB
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
